id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-292952-z7ajsf2r	Wong, Anselm	COVID‐19 and toxicity from potential treatments: Panacea or poison	2020-05-12		.txt	text/plain	1425	97	53	One of the repercussions of promotion of medications/treatments prior to the results of large robust clinical trials being available is that people may start to self-medicate and potentially overdose. As emergency doctors, we need to be able to tease out the disease process of COVID-19 from potential side effects of trial medications or overdose of these. A small (n = 42), non-randomised open label trial showed decreased viral load in patients receiving hydroxychloroquine (600 mg daily for 10 days) and azithromycin. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial No evidence of clinical efficacy of hydroxychloroquine in patients hospitalised for COVID-19 infection and requiring oxygen: results of a study using routinely collected data to emulate a target trial Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial	./cache/cord-292952-z7ajsf2r.txt	./txt/cord-292952-z7ajsf2r.txt